PARP inhibitors in ovarian cancer: An overview of the practice‐changing trials
Author:
Affiliation:
1. Gynaecology Unit The Royal Marsden NHS Foundation Trust London UK
2. Department of Cancer Genetics The Royal Marsden NHS Foundation Trust London UK
3. Division of Clinical Studies The Institute of Cancer Research London UK
Publisher
Wiley
Subject
Cancer Research,Genetics
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22935
Reference87 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Ovarian Cancer—Cancer Stat Facts. Accessed July 1 2020.https://seer.cancer.gov/statfacts/html/ovary.html.
3. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow‐up †;Ledermann JA;ESMO Update Clin Pract Guideline,2013
4. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
5. A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cell‐free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer;Molecular Oncology;2024-08-08
2. Spatial tumor immune microenvironment phenotypes in ovarian cancer;npj Precision Oncology;2024-07-18
3. Targeting Cancer Stem Cells with Radioimmunotherapy: The Case of the Ovarian Cancer Stemness-Associated Biomarker L1CAM;International Journal of Translational Medicine;2024-07-18
4. PARP inhibitors in ovarian cancer therapy;Prospects in Pharmaceutical Sciences;2024-06-18
5. Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecologic Cancers;Cancer Research Communications;2024-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3